Bristol Myers Squibb
Forbes Global 2000 1887 #188 by revenue United States Healthcare Drugs & Biotechnology bms.com
Bristol Myers Squibb Co.
Forbes Global 2000's description, shown to identify the company. We rate the name, not the business.
- Evocativity EVOC : red
- Surname sequence gives no medicine cue
- Brevity BREV : red
- 18 letters, 4 syllables. Up to seven letters is green, eight at two syllables too; up to ten yellow, eleven or more red.
- Greppability GREP : green
- Found inside 0 other dictionary words.
- Googlability GOOG : green
- Distinctive complete name combination
- Pronounceability PRON : yellow
- Squibb and surname boundaries may be unfamiliar
- Spellability SPEL : red
- Myers versus Meyers and double b are uncertain
- Verbability VERB : red
- Long surname sequence resists verb use
- Nominology
- 30
- All seven dimensions and .com ownership, weighted as set out on Methodology.
- Fluency
- 30
- Brevity and pronounceability only: the subset with published outcome evidence behind it.
- PG grade
- 3 / 4
- Graham's own four-step ladder.
- Exact .com
- Not owned
- Shape
- phrase
- Length
- 20 chars, 4 syllables
- Distinctiveness
- arbitrary
Watkins SCRATCH flags
- Spelling-challenged
Rubric version 2026.10.20-1, judged by gpt-6.1-sol (agent).
This scores the name only. See Methodology.
These judged dimensions came from an AI agent working through the judging queue in a chat, on the same rubric the scoring pipeline sends. The agent passed the calibration exam before its work was accepted, and each batch it judged hid two names with known answers as a check. The model is named as the agent reported it.